Clinical Trials Logo

Filter by:
NCT ID: NCT03856814 Completed - Varicose Veins Clinical Trials

Market Penetration of Laser Therapy in Venous Surgery: Ziekenhuis Oost-Limburg - Ziekenhuis Maas en Kempen Center Experience

Start date: March 15, 2019
Phase:
Study type: Observational [Patient Registry]

The goal of this registry is to evaluate the indication for EndoVenous Laser Ablation (EVLA) therapy. Can this be enhanced? What are the reasons for not using the laser? Therefore, this study aims to define clear indications for EVLA by registering the incentives of the participating investigators to use the laser instead of conventional corrective surgery for the treatment of varicose veins, at baseline and post-operative. Additionally, the efficacy and safety of the different varicose vein treatments will be evaluated by registering procedural characteristics, anatomic outcome (duplex ultrasound), quality of life (AVVQ) and postoperative pain (VAS).

NCT ID: NCT03856294 Completed - Dyspepsia Clinical Trials

The Effect of Rikkunshito on Gastric Accommodation and Nutrient Volume Tolerance in Functional Dyspepsia

Start date: December 2015
Phase: Phase 2
Study type: Interventional

Functional dyspepsia (FD) is a common chronic gastrointestinal (GI) disorder. Rikkunshito, a traditional Japanese Kampo medicine, has shown efficacy in improving FD symptoms in controlled trials in Japan. Its putative benefit for European patients has never been investigated. Further, its exact mechanism of action is incompletely elucidated. This study aimed to examine the effect of rikkunshito on gastric motility and GI symptom perception in FD in a randomized, placebo-controlled, cross-over study. Intragastric pressure (IGP) was assessed using high-resolution manometry as an indirect measurement of gastric accommodation and gastric motility.

NCT ID: NCT03855969 Completed - Oncology Clinical Trials

Central Venous Access Device Removal in Cancer Patients

Start date: March 1, 2019
Phase:
Study type: Observational

Background: Central venous catheters are frequently used during cancer treatment with the aim of venepreservation. It can facilitate venous access for the safe administration of irritating or vesicant intravenous cancer medications and / or other fluids, to collect blood samples or to ensure accurate venous access for contrast during medical imaging. In addition, this means more comfort for the patient who needs to be punctured less peripherally. However, central venous catheters can also be a source of bloodstream infections and other complications, leading to increased morbidity and hospital costs (1). In our hospital, there is a general practice that if an infection of the device is suspected, the central venous catheter should be removed if antibiotics do not seem or prove to be effective. The objective of this trial is to assess the frequency of implanted port catheter-removal in cancer patients due to suspected infection of the device in a particular oncology center over a time period of seven years. Furthermore, evidence for real device infections (per/post-surgery) and the potential contribution of different (institution-specific) risk factors on device infection will be explored. There will be focused on implanted port catheters only, as this is the main used central venous access device within the oncological population. Trial objectives: The primary aim of this retrospective descriptive trial is to evaluate the frequency of implanted port catheter-removal in cancer patients due to suspected infection of the device, over a time period of seven years. The secondary aim is to examine whether the device infection could be confirmed during or after removal of the device. At last, the tertiary aim is to verify whether certain variables can be denoted as potential risk factors for central venous access infection. Selection of those variables of interest will be based on a thorough review of the literature and discussion with the responsible healthcare professionals.

NCT ID: NCT03854708 Completed - Hunger Clinical Trials

Effect of Pancreatic Polypeptide on Gastric Motor Function and Food Intake in Humans

Start date: August 31, 2010
Phase: Phase 4
Study type: Interventional

The investigators want to observe whether different doses of pancreatic polypeptide infusions influence gastric accommodation (measured as intragastric pressure changes during a liquid meal infusion), gastric emptying and food intake.

NCT ID: NCT03853642 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Blood Eosinophil Measurements in Patients With Chronic Obstructive Pulmonary Disease

Start date: March 1, 2019
Phase:
Study type: Observational [Patient Registry]

This study will assess the within-day variation of blood eosinophils in patients with Chronic Obstructive Pulmonary disease (COPD) in stable state and determine if there is a correlation between the blood eosinophils and certain clinical parameters.

NCT ID: NCT03853109 Completed - Clinical trials for Advanced Solid Tumors

AMG 404 in Patients With Advanced Solid Tumors

Start date: March 5, 2019
Phase: Phase 1
Study type: Interventional

To evaluate the safety and tolerability of AMG 404, a monoclonal antibody that binds to PD-1 and inhibits its engagement with ligands, in patients with advanced solid tumors.

NCT ID: NCT03853018 Completed - Sedentary Lifestyle Clinical Trials

Effectiveness of Activity Trackers to Reduce Sedentary Behaviour in Sedentary Adults

CWATLDP
Start date: November 15, 2018
Phase: N/A
Study type: Interventional

This study evaluates the effectiveness of consumer wearable activity trackers to reduce sedentary behaviour and the impact on cardiometabolic health.

NCT ID: NCT03852667 Completed - Clinical trials for Low Back Pain, Recurrent

The Effect of Secondary Prevention in Patients With Recurrent Low Back Pain

Start date: September 29, 2019
Phase: N/A
Study type: Interventional

This study investigates the effect of a secondary intervention program for low back pain in patients with recurrent low back pain. One third of the subject will receive no therapy, one third wil receive 2 sessions of pain neuroscience education (PNE) and one third will receive two sessions of PNE and 5 sessions of exercise therapy over 6 weeks.

NCT ID: NCT03849677 Completed - Healthy Clinical Trials

Uric Acid Metabolism, Endothelial Function and Oxidative Stress in Vegans and Omnivores.

Start date: March 10, 2019
Phase:
Study type: Observational

50 vegans and 50 omnivores will be recruited at the Erasme Hospital, Brussels. Hypothesis - Relative induced-hyperuricemia by the vegan diet is not associated with impaired endothelial function if vitamin B12 and folic acid levels are normal. - Quantification of xanthine oxidoreductase (XOR) isoforms varies according to the diet. Omnivores present more xanthine oxidase (XO) than vegans in which the xanthine dehydrogenase (XD) isoform is more prevalent. - The vegan group has more favorable oxidant, metabolic and inflammatory profiles than the omnivore group.

NCT ID: NCT03849118 Completed - Clinical trials for Clear Cell Renal Cell Carcinoma

89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study

89ZR-TLX250
Start date: August 15, 2019
Phase: Phase 3
Study type: Interventional

89Zr-TLX250 is under clinical development as a diagnostic agent targeting clear cell renal cell carcinoma.